tradingkey.logo
tradingkey.logo
검색

AtriCure Inc

ATRC
관심 목록에 추가
31.345USD
+1.615+5.43%
종가 07/02, 13:00ET시세는 15분 지연됩니다
1.56B시가총액
손실P/E TTM

자세한 내용은 AtriCure Inc 회사

AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.

AtriCure Inc 정보

종목 코드 ATRC
회사 이름AtriCure Inc
상장일Aug 05, 2005
CEOCarrel (Michael H)
직원 수1300
유형Ordinary Share
회계 연도 종료Aug 05
주소7555 Innovation Way
도시MASON
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호45040
전화15137554100
웹사이트https://www.atricure.com
종목 코드 ATRC
상장일Aug 05, 2005
CEOCarrel (Michael H)

AtriCure Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
796.06K
+12.20%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
158.05K
+20.54%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
128.32K
+4.79%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
106.40K
+25.94%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
96.05K
+28.63%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
91.88K
-5.44%
Mr. Sven A. Wehrwein, CPA
Mr. Sven A. Wehrwein, CPA
Independent Director
Independent Director
40.52K
+15.16%
Ms. Regina E. (Reggie) Groves
Ms. Regina E. (Reggie) Groves
Independent Director
Independent Director
39.86K
+15.41%
Ms. Deborah H. (Deb) Telman
Ms. Deborah H. (Deb) Telman
Independent Director
Independent Director
28.33K
+21.69%
Mr. Shlomo Nachman
Mr. Shlomo Nachman
Independent Director
Independent Director
24.66K
+24.92%
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
796.06K
+12.20%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
158.05K
+20.54%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
128.32K
+4.79%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
106.40K
+25.94%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
96.05K
+28.63%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
91.88K
-5.44%

자주 묻는 질문

AtriCure Inc의 상위 5대 주주는 누구인가요?

AtriCure Inc의 상위 5대 주주는 다음과 같습니다: Mr. Michael H. (Mike) Carrel, CPA

AtriCure Inc(ATRC)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, AtriCure Inc의 주식을 보유한 기관은 총 505곳이며, 이들이 보유한 주식의 총 가치는 약 48.18M로 전체 발행 주식의 95.14%를 차지합니다. 이는 2025Q4 대비 -7010307.00 증가한 수치입니다.

AtriCure Inc의 최대 수익원은 무엇인가요?

2026Q1 기준, AtriCure Inc의 Appendage Management-United states 부문이 가장 높은 매출을 기록했으며, 금액은 178.13M로 전체 매출의 33.32%를 차지했습니다.